Advertisement
U.S. markets closed

Myrexis, Inc. (MYRX)

Other OTC - Other OTC Delayed Price. Currency in USD
0.01050.0000 (0.00%)
At close: 01:50PM EDT

Myrexis, Inc.

630 Fifth Avenue
Suite 2260
New York, NY 10020
United States
801-214-7800
https://www.myrexis.com

Sector(s)Financial Services
IndustryShell Companies
Full Time Employees1

Key Executives

NameTitlePayExercisedYear Born
Mr. Jonathan M. CouchmanChairman, CEO, President, CFO & Principal Accounting Officer1N/A1970
Amounts are as of December 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

Corporate Governance

Myrexis, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.